Eric Gershenbaum
Ophthalmology · Freehold, NJNPI 1548227309
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $16,982 of the $22,687 with a category attached, or 74.9%. 29 manufacturers reported payments, led by Johnson & Johnson Surgical Vision, Inc. at 26.4% of the total. Reporting peaked in 2022 at $5,968 and has fallen 56.3% since, to $2,610 in 2025. Among ophthalmology clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 355 payments — averaging $63.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson Surgical Vision, Inc.$6K
- Glaukos Corporation$3K
- AbbVie$3K
- Sight Sciences, Inc.$2K
- Carl Zeiss Meditec USA, Inc.$2K
- Alcon$1K
- plus $6K from 23 others
What the payments were for
- Consulting fees$1,3356%
- Speaking & faculty fees$3331%
- Grants$2,31010%
- Travel & lodging$1,6827%
- Food & beverage$16,98275%
- Gifts$450%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | 89 | $5,981 |
| Glaukos Corporation | 25 | $2,784 |
| AbbVie(2 entities) | 23 | $2,670 |
| Sight Sciences, Inc. | 33 | $2,420 |
| Carl Zeiss Meditec USA, Inc. | 3 | $1,871 |
| Alcon | 33 | $1,304 |
| Bausch & Lomb Americas Inc. | 16 | $1,041 |
| Lumenis BE Inc | 1 | $959 |
| NEW World Medical,inc. | 2 | $583 |
| Rxsight Inc | 7 | $549 |
| Novartis | 40 | $455 |
| Kala Pharmaceuticals, Inc. | 22 | $386 |
| Sun Pharmaceutical Industries Inc. | 14 | $305 |
| Apellis Pharmaceuticals, Inc. | 5 | $296 |
| Biotissue Holdings Inc. | 4 | $190 |
| Aerie Pharmaceuticals, Inc. | 2 | $151 |
| Ocular Therapeutix, Inc. | 2 | $140 |
| Revance Therapeutics, Inc. | 2 | $133 |
| Genentech USA, Inc. | 5 | $98 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 7 | $97 |
| Oyster Point Pharma, Inc. | 4 | $57 |
| Eyepoint US, Inc. | 4 | $52 |
| Eyevance Pharmaceuticals LLC | 3 | $42 |
| Omeros Corporation | 2 | $33 |
| Johnson & Johnson | 2 | $28 |
| Shire North American Group Inc | 2 | $26 |
| Rayner Intraocular Lenses Limited | 1 | $13 |
| Beaver-visitec International, Inc. | 1 | $12 |
| Regeneron Healthcare Solutions, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMNI(R) SURGICAL SYSTEM (US)$2,032
- ARTEVO 800$1,803
- CIRRUS HD-OCT$1,803
- IOLMaster 700$1,803
- VERACITY SURGICAL$1,803
- VisuMax$1,803
- DURYSTA$1,258
- VUITY$1,155
- XEN GLAUCOMA TREATMENT SYSTEM$1,155
- optilight$959
- iStent inject Trabecular Micro-Bypass Stent System$738
- CATALYS SYSTEM$633
- Tecnis IOL$625
- Photrexa$609
- iDoseTR$501
- enVista MX60 IOL$488
- STELLARIS$419
- iStent$332
- RXSIGHT CONTACT LENS$305
- RXSIGHT INJECTOR CARTRIDGE$305
How this compares
$22,687 in reported general payments places this provider in the 95th percentile of 583 ophthalmology providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 17 | $5,654 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan | $2,670 | $5,65417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Freehold
- Rajen DesaiFreehold$311K
- Alain BauzaFreehold$58K
- Revathi NaadimuthuFreehold$12K
- Jai ParekhWoodland Park$2M
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Cynthia MatossianPennington$655K
- Eric MannDover$604K
- Brett BieloryRutherford$477K
- Albert KhouriNewark$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.